Skip to main content

Advertisement

Log in

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

  • Brief Reports
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2000;12(2).

  2. Celentano DD, Galai N, Sethi AK, et al. Time to initiating antiretroviral therapy among HIV-infected drug users. AIDS. 2001;15:1707–15.

    Article  PubMed  CAS  Google Scholar 

  3. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. JAMA. 1999;281:2305–15.

    Article  PubMed  CAS  Google Scholar 

  4. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280:547–9.

    Article  PubMed  CAS  Google Scholar 

  5. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV infection. J Acquire Immune Defic Syndr. 2001;27:251–9.

    CAS  Google Scholar 

  6. Haubrich RH, Little S, Currier JS, Forthal DN, Kemper C. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099–107.

    Article  PubMed  CAS  Google Scholar 

  7. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386–95.

    PubMed  CAS  Google Scholar 

  8. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychchol. 1989;56:267–83.

    Article  CAS  Google Scholar 

  9. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824–30.

    PubMed  CAS  Google Scholar 

  10. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz H. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763–9.

    Article  PubMed  CAS  Google Scholar 

  11. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12:255–66.

    Article  PubMed  CAS  Google Scholar 

  12. Stein MD, Rich JD, Maksad J, et al. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Abuse. 2000;26:195–205.

    Article  PubMed  CAS  Google Scholar 

  13. Johnston Roberts K, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care. 2000;12:377–86.

    Article  Google Scholar 

  14. Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care. 2000;38:911–25.

    Article  PubMed  CAS  Google Scholar 

  15. Moore J, Schuman P, Schoenbaum EE, Boland B, Solomon L, Smith DK. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS. 1999;13:2459–68.

    Article  PubMed  CAS  Google Scholar 

  16. Avants SK, Margolin A, Warburton LA, Hawkins KA, Shi J. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict. 2001;10:69–78.

    Article  PubMed  CAS  Google Scholar 

  17. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.

    Article  PubMed  CAS  Google Scholar 

  18. Kastrissios H, Suarez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke TF. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS. 1998;12:2295–303.

    Article  PubMed  CAS  Google Scholar 

  19. Liu H, Golin C, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968–77.

    PubMed  CAS  Google Scholar 

  20. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city HIV clinic. Clin Infect Dis. 2001;33:700–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julia H. Arnsten MD, MPH.

Additional information

This study was funded by the National Institute on Drug Abuse (R01-DA11869, R01-DA104347), and by a Robert Wood Johnson Generalist Physician Faculty Scholar Award to Dr. Arnsten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arnsten, J.H., Demas, P.A., Grant, R.W. et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J GEN INTERN MED 17, 377–381 (2002). https://doi.org/10.1007/s11606-002-0044-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-002-0044-3

Key Words

Navigation